Skip to main content

Table 1 Details of further diagnostic workup of men with an elevated PSA.

From: A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

  Men not undergoing subsequent biopsy N = 259 Men who received a biopsy N = 370
Repeat PSA 72 (28%) 51 (14%)
   PSA 3.1 (2.4, 3.6) 4.6 (3.6, 7.2)
   PSA < 3 ng/ml (% of those with second PSA) 34 (47%) 5 (10%)
Digital rectal exam 114 (44%) 333 (90%)
   Abnormal findings (% of those with DRE) 16 (14%) 115 (35%)